NCT00611351 2023-10-23Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic CancerUniversity of NebraskaPhase 2 Completed5 enrolled 10 charts
NCT00691652 2019-11-27Clofarabine and Rituximab in Treating Patients With Relapsed Non-Hodgkin LymphomaOHSU Knight Cancer InstitutePhase 1/2 Terminated2 enrolled 4 charts
NCT00049504 2017-05-17Haploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic CancerFred Hutchinson Cancer CenterPhase 2 Completed53 enrolled 10 charts